Probing the binding pocket of the active site of aromatase with 6-ether or 6-ester substituted androst-4-ene-3,17-diones and their diene and triene analogs
摘要:
A series of 6-ester- (3 and 4) and 6-ether- (7 and 8) substituted androst-4-ene-3,17-diones (androstenediones) and their 1,4-diene analogs (5 and 6, and 9 and 10) as well as CB-substituted 4,6-diene and 1,4,6-triene steroids 11 and 12 were synthesized as aromatase inhibitors to gain insight into the structure-activity relationship between various substituents and inhibitory activity. All of the inhibitors synthesized blocked aromatase in a competitive manner. The inhibitory activities of all of the steroids, except for the 6 beta -benzoates 4g and 6h and the 6 beta -acetate 6a, were fairly effective to very powerful (K-i: 7.0 -320 nM). The 6 alpha -n-hexanoyloxy- and 6 alpha -benzyloxyandrostenediones (3e and 7e) were the most potent inhibitors (K-i: 7.0 nM each). In the series of 4-ene and 1,4-diene steroids, the 6 alpha -substituted steroids had higher affinity for the enzyme than the corresponding 6 beta -isomers. In the 1,4-diene steroid series, 6 beta -substituted steroids 6a, e, g, and 10a, b, e caused a time-dependent inactivation of aromatase, whereas their 6 alpha -isomers 5 and 9 essentially did not. The ether-substituted 1,4,6-trienes 12 inactivated the enzyme in a time-dependent manner; in contrast, their 4,6-diene analogs 11 did not. The substrate androstenedione blocked the inactivation, but no significant effect of L-cysteine was observed. Based on molecular modeling with the PM3 method, along with the present inhibition and inactivation results, it is thought that both the steric effects of the 6-substituents as well as the electronic effects of the C-6 oxygen functions play a critical role in the binding of inhibitors to the active site of aromatase. (C) 2000 Elsevier Science Inc. All rights reserved.
Probing the binding pocket of the active site of aromatase with 6-ether or 6-ester substituted androst-4-ene-3,17-diones and their diene and triene analogs
摘要:
A series of 6-ester- (3 and 4) and 6-ether- (7 and 8) substituted androst-4-ene-3,17-diones (androstenediones) and their 1,4-diene analogs (5 and 6, and 9 and 10) as well as CB-substituted 4,6-diene and 1,4,6-triene steroids 11 and 12 were synthesized as aromatase inhibitors to gain insight into the structure-activity relationship between various substituents and inhibitory activity. All of the inhibitors synthesized blocked aromatase in a competitive manner. The inhibitory activities of all of the steroids, except for the 6 beta -benzoates 4g and 6h and the 6 beta -acetate 6a, were fairly effective to very powerful (K-i: 7.0 -320 nM). The 6 alpha -n-hexanoyloxy- and 6 alpha -benzyloxyandrostenediones (3e and 7e) were the most potent inhibitors (K-i: 7.0 nM each). In the series of 4-ene and 1,4-diene steroids, the 6 alpha -substituted steroids had higher affinity for the enzyme than the corresponding 6 beta -isomers. In the 1,4-diene steroid series, 6 beta -substituted steroids 6a, e, g, and 10a, b, e caused a time-dependent inactivation of aromatase, whereas their 6 alpha -isomers 5 and 9 essentially did not. The ether-substituted 1,4,6-trienes 12 inactivated the enzyme in a time-dependent manner; in contrast, their 4,6-diene analogs 11 did not. The substrate androstenedione blocked the inactivation, but no significant effect of L-cysteine was observed. Based on molecular modeling with the PM3 method, along with the present inhibition and inactivation results, it is thought that both the steric effects of the 6-substituents as well as the electronic effects of the C-6 oxygen functions play a critical role in the binding of inhibitors to the active site of aromatase. (C) 2000 Elsevier Science Inc. All rights reserved.
Probing the binding pocket of the active site of aromatase with 6-ether or 6-ester substituted androst-4-ene-3,17-diones and their diene and triene analogs
A series of 6-ester- (3 and 4) and 6-ether- (7 and 8) substituted androst-4-ene-3,17-diones (androstenediones) and their 1,4-diene analogs (5 and 6, and 9 and 10) as well as CB-substituted 4,6-diene and 1,4,6-triene steroids 11 and 12 were synthesized as aromatase inhibitors to gain insight into the structure-activity relationship between various substituents and inhibitory activity. All of the inhibitors synthesized blocked aromatase in a competitive manner. The inhibitory activities of all of the steroids, except for the 6 beta -benzoates 4g and 6h and the 6 beta -acetate 6a, were fairly effective to very powerful (K-i: 7.0 -320 nM). The 6 alpha -n-hexanoyloxy- and 6 alpha -benzyloxyandrostenediones (3e and 7e) were the most potent inhibitors (K-i: 7.0 nM each). In the series of 4-ene and 1,4-diene steroids, the 6 alpha -substituted steroids had higher affinity for the enzyme than the corresponding 6 beta -isomers. In the 1,4-diene steroid series, 6 beta -substituted steroids 6a, e, g, and 10a, b, e caused a time-dependent inactivation of aromatase, whereas their 6 alpha -isomers 5 and 9 essentially did not. The ether-substituted 1,4,6-trienes 12 inactivated the enzyme in a time-dependent manner; in contrast, their 4,6-diene analogs 11 did not. The substrate androstenedione blocked the inactivation, but no significant effect of L-cysteine was observed. Based on molecular modeling with the PM3 method, along with the present inhibition and inactivation results, it is thought that both the steric effects of the 6-substituents as well as the electronic effects of the C-6 oxygen functions play a critical role in the binding of inhibitors to the active site of aromatase. (C) 2000 Elsevier Science Inc. All rights reserved.